Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
US7115554B1 · kind B1 · utility
14Cited by
5References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 1994 |
| Grant date | Oct 3, 2006 |
| Priority date | — |
| Expiry date | Mar 8, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods of treating diseases and disorders of the muscle tissues in a vertebrate by the administration of compounds which bind the p185erbB2 receptor. These compounds are found to cause increased differentiation and survival of cardiac, skeletal and smooth muscle.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.